Bausch + Lomb Corporation

Bausch + Lomb Corporation

$20.74
-0.13 (-0.62%)
New York Stock Exchange
USD, CA
Medical - Instruments & Supplies

BLCO Price Chart

Basic
Market Cap$6.7B
Price$20.74
52 Week Range13.16-21.0
Beta0.46
Margins
Gross Profit Margin57.55%
Operating Profit Margin3.20%
Net Profit Margin-10.14%
Valuation (TTM)
P/E Ratio-16.00
Price to Sales Ratio1.62
Price to Book Ratio1.12
PEG Ratio0.45

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Full-Time Employees

13,000

IPO Date

2022-05-06T00:00:00.000Z

Description

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.

Phone

905 695 7700

Address

520 Applewood Crescent, Vaughan, ON, L4K 4B4, CA

CIK

0001860742